Results 121 to 130 of about 2,627 (188)

NEO1 modulates the A1 astrocyte polarization in subarachnoid hemorrhage through the cPLA2-MAVS signaling pathway. [PDF]

J Neuroinflammation
Wu Y, Wei B, Jin L, Li L, Yang Z, Li C, Zhou J, Gong W, Feng X, Guo S, Cheng W, Li R, Liang S, Su S, Jin F, Zhang X, Liu Y, Duan C, Li X, Liu W.   +19 more
europepmc   +1 more source

Repurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.

Mol Genet Metab
Minea C, Deegan PB.
europepmc   +1 more source

Monoclonal IgM antibodies mediate potent complement neutralization by targeting cell-derived epitopes on enveloped viruses. [PDF]

mBio
Kainulainen MH, Harmon JR, Bergeron É, Davies KA, LeBlanc ML, Clines C, Bentz ML, Montgomery JM, Spiropoulou CF.   +8 more
europepmc   +1 more source

New drugs: Miglustat

Australian Prescriber, 2010
openaire   +1 more source

Inflammatory response in CF airway epithelial cells: a comparative study of modulators and wild-type CFTR rescue. [PDF]

Front Pharmacol
Kouadri A, Lyko C, El Hajjar C, Cormenier J, Kevin Gemy K, Alfaidy N, Benharouga M.   +6 more
europepmc   +1 more source

Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C. [PDF]

Neurology
Patterson MC, Ramaswami U, Donald A, Foltan T, Gautschi M, Gissen P, Hahn A, Jones SA, Kay R, Kolniková M, Park J, Reichmannová S, Walterfang M, Wibawa P, Rohrbach M, Martakis K, Bremova-Ertl T.   +16 more
europepmc   +1 more source

Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1. [PDF]

Genet Med Open
Cawley NX, Zhou R, Mylvara A, Padilla CJ, Alexander D, Farhat N, Alvarez C, Cougnoux A, Berry-Kravis E, Cologna SM, Liu F, Porter FD.   +11 more
europepmc   +1 more source

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis. [PDF]

Orphanet J Rare Dis
Corbett M, Umemneku-Chikere C, Nevitt S, Deng NJ, Walton M, Fulbright H, Tan CY, Lachmann R, Churchill R, Hodgson R.   +9 more
europepmc   +1 more source

Drug-induced urinary incontinence in pediatric patients: A disproportionality analysis of the FDA Adverse Event Reporting System. [PDF]

Medicine (Baltimore)
Jin C, Zhang X, Ouyang X, Lou Q.
europepmc   +1 more source

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS. [PDF]

Eur J Health Econ
Walton M, Deng NJ, Corbett M, Umemneku-Chikere C, Nevitt S, Fulbright H, Tan CY, Lachmann R, Churchill R, Hodgson R.   +9 more
europepmc   +1 more source